Carnegie Investment Counsel’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $298K | Sell |
4,220
-30
| -0.7% | -$2.25K | 0.01% | 482 |
|
|
2025
Q4 | $335K | Hold |
4,250
| – | – | 0.01% | 461 |
|
|
2025
Q3 | $350K | Sell |
4,250
-900
| -17% | -$70.8K | 0.01% | 451 |
|
|
2025
Q2 | $414K | Sell |
5,150
-400
| -7% | -$30.9K | 0.01% | 424 |
|
|
2025
Q1 | $386K | Sell |
5,550
-411
| -7% | -$34.2K | 0.01% | 401 |
|
|
2024
Q4 | $488K | Sell |
5,961
-70
| -1% | -$5.83K | 0.01% | 343 |
|
|
2024
Q3 | $497K | Buy |
6,031
+494
| +9% | +$36.9K | 0.01% | 336 |
|
|
2024
Q2 | $389K | Sell |
5,537
-1,250
| -18% | -$89.2K | 0.01% | 369 |
|
|
2024
Q1 | $503K | Buy |
6,787
+882
| +15% | +$61.5K | 0.02% | 355 |
|
|
2023
Q4 | $390K | Buy |
5,905
+253
| +4% | +$15.8K | 0.01% | 386 |
|
|
2023
Q3 | $356K | Sell |
5,652
-196
| -3% | -$12.2K | 0.01% | 386 |
|
|
2023
Q2 | $331K | Sell |
5,848
-1,085
| -16% | -$60.2K | 0.01% | 411 |
|
|
2023
Q1 | $402K | Sell |
6,933
-148
| -2% | -$9.99K | 0.02% | 384 |
|
|
2022
Q4 | $512K | Sell |
7,081
-943
| -12% | -$67.5K | 0.02% | 348 |
|
|
2022
Q3 | $488K | Buy |
8,024
+2,158
| +37% | +$138K | 0.02% | 336 |
|
|
2022
Q2 | $368K | Hold |
5,866
| – | – | 0.02% | 376 |
|
|
2022
Q1 | $412K | Buy |
5,866
+468
| +9% | +$31.6K | 0.02% | 371 |
|
|
2021
Q4 | $337K | Buy |
5,398
+495
| +10% | +$31.1K | 0.01% | 406 |
|
|
2021
Q3 | $303K | Sell |
4,903
-229
| -4% | -$13.8K | 0.01% | 385 |
|
|
2021
Q2 | $307K | Sell |
5,132
-300
| -6% | -$19K | 0.01% | 389 |
|
|
2021
Q1 | $330K | Hold |
5,432
| – | – | 0.01% | 366 |
|
|
2020
Q4 | $255K | Sell |
5,432
-1,027
| -16% | -$44.5K | 0.01% | 382 |
|
|
2020
Q3 | $240K | Sell |
6,459
-989
| -13% | -$37.5K | 0.01% | 372 |
|
|
2020
Q2 | $272K | Sell |
7,448
-971
| -12% | -$33.8K | 0.02% | 354 |
|
|
2020
Q1 | $257K | Sell |
8,419
-2,732
| -25% | -$121K | 0.02% | 339 |
|
|
2019
Q4 | $568K | Sell |
11,151
-896
| -7% | -$43.3K | 0.03% | 290 |
|
|
2019
Q3 | $568K | Sell |
12,047
-6,427
| -35% | -$306K | 0.04% | 277 |
|
|
2019
Q2 | $918K | Sell |
18,474
-396
| -2% | -$18.6K | 0.06% | 225 |
|
|
2019
Q1 | $803K | Sell |
18,870
-2,831
| -13% | -$125K | 0.06% | 235 |
|
|
2018
Q4 | $891K | Sell |
21,701
-32,258
| -60% | -$1.38M | 0.08% | 199 |
|
|
2018
Q3 | $2.38M | Buy |
53,959
+20,144
| +60% | +$920K | 0.19% | 125 |
|
|
2018
Q2 | $1.52M | Sell |
33,815
-3,061
| -8% | -$143K | 0.12% | 166 |
|
|
2018
Q1 | $1.73M | Sell |
36,876
-416
| -1% | -$20.2K | 0.14% | 145 |
|
|
2017
Q4 | $1.73M | Buy |
37,292
+2,767
| +8% | +$146K | 0.15% | 163 |
|
|
2017
Q3 | $1.84M | Buy |
34,525
+421
| +1% | +$20.5K | 0.22% | 120 |
|
|
2017
Q2 | $1.69M | Buy |
34,104
+1,964
| +6% | +$91.1K | 0.21% | 128 |
|
|
2017
Q1 | $1.5M | Buy |
32,140
+5,614
| +21% | +$268K | 0.19% | 131 |
|
|
2016
Q4 | $1.27M | Sell |
26,526
-54
| -0.2% | -$2.48K | 0.17% | 136 |
|
|
2016
Q3 | $1.11M | Sell |
26,580
-5,996
| -18% | -$225K | 0.16% | 141 |
|
|
2016
Q2 | $1.25M | Buy |
32,576
+4,213
| +15% | +$164K | 0.18% | 139 |
|
|
2016
Q1 | $1.11M | Buy |
28,363
+6
| +0% | +$224 | 0.17% | 145 |
|
|
2015
Q4 | $1.13M | Buy |
28,357
+881
| +3% | +$38.7K | 0.2% | 127 |
|
|
2015
Q3 | $1.21M | Buy |
27,476
+6,585
| +32% | +$308K | 0.21% | 117 |
|
|
2015
Q2 | $1.04M | Buy |
20,891
+9
| +0% | +$426 | 0.18% | 130 |
|
|
2015
Q1 | $939K | Buy |
20,882
+2,977
| +17% | +$134K | 0.16% | 138 |
|
|
2014
Q4 | $830K | Buy |
17,905
+4,314
| +32% | +$205K | 0.16% | 138 |
|
|
2014
Q3 | $651K | Buy |
+13,591
| New | +$660K | 0.13% | 162 |
|
Other funds holding MET
VCM
VPM
Carnegie Investment Counsel's MET Position: Q1 2026 in Review
Carnegie Investment Counsel reduced its MetLife (MET) stake by 0.71% in Q1 2026, selling an estimated $2.25K and leaving 4,220 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #482.
Carnegie Investment Counsel first reported a position in MET in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.38M in Q3 2018. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Carnegie Investment Counsel held 4,220 shares of MetLife worth $298K as of Q1 2026.
- Carnegie Investment Counsel sold 30 MetLife shares in Q1 2026, an estimated $2.25K.
- MetLife made up 0.01% of Carnegie Investment Counsel's portfolio in Q1 2026, its #482 holding.
- Carnegie Investment Counsel first reported a position in MetLife in Q3 2014 and has held it in 47 quarters since.
- Carnegie Investment Counsel's MetLife position peaked at $2.38M in Q3 2018.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.